News|Articles|January 2, 2019

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2019
  • Volume 43
  • Issue 1

Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules

This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.

Soft gelatin capsules (SGC) are popularly used pharmaceutical dosage forms, whose critical quality attributes are efficient opening/rupture, disintegration, and dissolution. Unlike oral capsules, however, rectal capsules must dissolve in minimal fluid and hydrodynamics, without digestive enzymes to break down the crosslinking of gelatin if any. Therefore, a reliable biomimetic method is needed to characterize SGC rupture/disintegration during rectal administration. This article demonstrates how qualitative physical attributes testing, a method that has recently been approved for use by the World Health Organization, can be used to achieve these goals.

Please click

here

for a PDF of the article.

Peer-Reviewed

Submitted: Sept. 4, 2018
Accepted: Oct. 16, 2018

About the author

Yasvanth Ashokraj*, yasvanth.ashokraj@cipla.com, Swati Laud, Kalpesh Sawant, Prashant Modak, and Praveen Date all work in Integrated Product Development at CIPLA.

*To whom all correspondence should be addressed.

Article Details

Pharmaceutical Technology
Vol. 43, No. 1
January 2019
Pages: 41–45

Citation

When referring to this article, please cite it as Y. Ashokraj et al., “Evaluating a New Quality Control Test for Soft Gelatin Rectal Capsules,” Pharmaceutical Technology 43 (1) 2019.

Articles in this issue

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.